GB9601041D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9601041D0 GB9601041D0 GBGB9601041.8A GB9601041A GB9601041D0 GB 9601041 D0 GB9601041 D0 GB 9601041D0 GB 9601041 A GB9601041 A GB 9601041A GB 9601041 D0 GB9601041 D0 GB 9601041D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9601041.8A GB9601041D0 (en) | 1996-01-17 | 1996-01-17 | Novel compounds |
| PCT/EP1997/000196 WO1997026257A1 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| KR1019980705472A KR19990077325A (en) | 1996-01-17 | 1997-01-14 | Hydroxamic Acid Collagenase Inhibitors |
| CN97192982A CN1213368A (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| HU9901022A HUP9901022A3 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| PL97327820A PL327820A1 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| CA002242913A CA2242913A1 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| TR1998/01380T TR199801380T2 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid-based collagenase inhibitors. |
| JP9525693A JP2000503312A (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid-based collagenase inhibitors |
| NZ326352A NZ326352A (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors useful in the treatment of and prophylaxis of disorders in which the overproduction of soluble CD23 is implicated |
| IL12538197A IL125381A0 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| EP97901055A EP0912545A1 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| CZ982224A CZ222498A3 (en) | 1996-01-17 | 1997-01-14 | Collagenase inhibitor based on hydroxamic acid, pharmaceutical preparation containing thereof, process of its preparation and use |
| BR9707024A BR9707024A (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| AU14436/97A AU725056B2 (en) | 1996-01-17 | 1997-01-14 | Hydroxamic acid based collagenase inhibitors |
| ARP970100153A AR005472A1 (en) | 1996-01-17 | 1997-01-15 | INHIBITORS OF THE HUMAN SOLUBLE CD23 TRAINING, A PROCEDURE FOR ITS PREPARATION, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION AND INTERMEDIARY COMPOUNDS |
| ZA97345A ZA97345B (en) | 1996-01-17 | 1997-01-16 | Novel compounds |
| TW086101017A TW462967B (en) | 1996-01-17 | 1997-01-30 | Hyroxamic acid derivatives useful for the treatment or prophylaxis of disorders associated with excess production of s-CD23 |
| NO983283A NO983283L (en) | 1996-01-17 | 1998-07-16 | Hydrocamic acid-based collagenase inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9601041.8A GB9601041D0 (en) | 1996-01-17 | 1996-01-17 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9601041D0 true GB9601041D0 (en) | 1996-03-20 |
Family
ID=10787226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9601041.8A Pending GB9601041D0 (en) | 1996-01-17 | 1996-01-17 | Novel compounds |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0912545A1 (en) |
| JP (1) | JP2000503312A (en) |
| KR (1) | KR19990077325A (en) |
| CN (1) | CN1213368A (en) |
| AR (1) | AR005472A1 (en) |
| AU (1) | AU725056B2 (en) |
| BR (1) | BR9707024A (en) |
| CA (1) | CA2242913A1 (en) |
| CZ (1) | CZ222498A3 (en) |
| GB (1) | GB9601041D0 (en) |
| HU (1) | HUP9901022A3 (en) |
| IL (1) | IL125381A0 (en) |
| NO (1) | NO983283L (en) |
| NZ (1) | NZ326352A (en) |
| PL (1) | PL327820A1 (en) |
| TR (1) | TR199801380T2 (en) |
| TW (1) | TW462967B (en) |
| WO (1) | WO1997026257A1 (en) |
| ZA (1) | ZA97345B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| GB9609795D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
| WO2000040713A1 (en) * | 1999-01-06 | 2000-07-13 | Mcmaster University | Method of preventing immune and hypersensitivity reactions |
| GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
| AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
| EP1469882B1 (en) * | 2002-01-28 | 2010-08-25 | Aimsco Limited | Treatment of nervous system diseases with goat serum |
| JPWO2006016399A1 (en) | 2004-08-10 | 2008-05-01 | 株式会社静岡カフェイン工業所 | Hydroxamic acid derivative and pharmaceutical comprising the same |
| KR100844277B1 (en) * | 2005-04-29 | 2008-07-07 | (주)아모레퍼시픽 | A hydroxamic acid derivative and the preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB9504084D0 (en) * | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
-
1996
- 1996-01-17 GB GBGB9601041.8A patent/GB9601041D0/en active Pending
-
1997
- 1997-01-14 WO PCT/EP1997/000196 patent/WO1997026257A1/en not_active Application Discontinuation
- 1997-01-14 AU AU14436/97A patent/AU725056B2/en not_active Ceased
- 1997-01-14 NZ NZ326352A patent/NZ326352A/en unknown
- 1997-01-14 BR BR9707024A patent/BR9707024A/en unknown
- 1997-01-14 EP EP97901055A patent/EP0912545A1/en not_active Withdrawn
- 1997-01-14 HU HU9901022A patent/HUP9901022A3/en unknown
- 1997-01-14 KR KR1019980705472A patent/KR19990077325A/en not_active Application Discontinuation
- 1997-01-14 JP JP9525693A patent/JP2000503312A/en active Pending
- 1997-01-14 TR TR1998/01380T patent/TR199801380T2/en unknown
- 1997-01-14 IL IL12538197A patent/IL125381A0/en unknown
- 1997-01-14 CA CA002242913A patent/CA2242913A1/en not_active Abandoned
- 1997-01-14 CZ CZ982224A patent/CZ222498A3/en unknown
- 1997-01-14 PL PL97327820A patent/PL327820A1/en unknown
- 1997-01-14 CN CN97192982A patent/CN1213368A/en active Pending
- 1997-01-15 AR ARP970100153A patent/AR005472A1/en unknown
- 1997-01-16 ZA ZA97345A patent/ZA97345B/en unknown
- 1997-01-30 TW TW086101017A patent/TW462967B/en active
-
1998
- 1998-07-16 NO NO983283A patent/NO983283L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990077325A (en) | 1999-10-25 |
| EP0912545A1 (en) | 1999-05-06 |
| TR199801380T2 (en) | 1998-10-21 |
| CN1213368A (en) | 1999-04-07 |
| IL125381A0 (en) | 1999-03-12 |
| ZA97345B (en) | 1998-07-16 |
| PL327820A1 (en) | 1999-01-04 |
| NZ326352A (en) | 2000-03-27 |
| AU725056B2 (en) | 2000-10-05 |
| AU1443697A (en) | 1997-08-11 |
| CZ222498A3 (en) | 1999-03-17 |
| WO1997026257A1 (en) | 1997-07-24 |
| NO983283D0 (en) | 1998-07-16 |
| JP2000503312A (en) | 2000-03-21 |
| HUP9901022A3 (en) | 2001-11-28 |
| TW462967B (en) | 2001-11-11 |
| NO983283L (en) | 1998-09-16 |
| CA2242913A1 (en) | 1997-07-24 |
| HUP9901022A2 (en) | 1999-07-28 |
| BR9707024A (en) | 1999-07-20 |
| AR005472A1 (en) | 1999-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0914330A4 (en) | Novel compounds | |
| EP0961618A4 (en) | Novel compounds | |
| EP0909181A4 (en) | Novel compounds | |
| GB9601067D0 (en) | Novel compounds | |
| EP0904105A4 (en) | Novel compounds | |
| AP9701047A0 (en) | Novel compounds | |
| GB9605945D0 (en) | Novel compounds | |
| GB9600955D0 (en) | Novel compounds | |
| AP9701037A0 (en) | Novel compounds | |
| GB9601041D0 (en) | Novel compounds | |
| GB9604045D0 (en) | Novel compounds | |
| GB9601069D0 (en) | Novel compounds | |
| GB9605883D0 (en) | Novel compounds | |
| EP0954525A4 (en) | Novel compounds | |
| GB9601068D0 (en) | Novel compounds | |
| GB9601099D0 (en) | Novel compounds | |
| GB9601066D0 (en) | Novel compounds | |
| GB9604582D0 (en) | Novel compounds | |
| GB9601096D0 (en) | Novel compounds | |
| GB9604583D0 (en) | Novel compounds | |
| GB9604594D0 (en) | Novel compounds | |
| GB9604581D0 (en) | Novel compounds | |
| GB9604580D0 (en) | Novel compounds | |
| GB9604574D0 (en) | Novel compounds | |
| GB9604417D0 (en) | Novel compounds |